Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intratumoral Injection”

163 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 163 results

Testing effectiveness (Phase 2)Study completedNCT02927964
What this trial is testing

TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma

Who this might be right for
Grade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular Lymphoma+4 more
Robert Lowsky 21
Testing effectiveness (Phase 2)Ended earlyNCT01984892
What this trial is testing

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Who this might be right for
MelanomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Skin+3 more
Nina Bhardwaj 8
Testing effectiveness (Phase 2)Study completedNCT02423863
What this trial is testing

In Situ, Autologous Therapeutic Vaccination Against Solid Cancers With Intratumoral Hiltonol®

Who this might be right for
MelanomaHead and Neck CancerSarcoma+1 more
Oncovir, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT02254772
What this trial is testing

A Phase I/II Study of Intratumoral Injection of SD-101

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
Robert Lowsky 9
Testing effectiveness (Phase 2)Study completedNCT04260529
What this trial is testing

CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations

Who this might be right for
Advanced Solid Tumor Malignancy
Cytovation AS 60
Early research (Phase 1)Looking for participantsNCT05338658
What this trial is testing

Study of PAT in Patients With Solid Tumor Cancers

Who this might be right for
MetastasisSolid Tumor
Masonic Cancer Center, University of Minnesota 21
Early research (Phase 1)Study completedNCT03010176
What this trial is testing

Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)

Who this might be right for
Solid TumorsLymphoma
Merck Sharp & Dohme LLC 156
Early research (Phase 1)Study completedNCT03739931
What this trial is testing

Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

Who this might be right for
Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or LymphomaDose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC Lymphoma
ModernaTX, Inc. 134
Large-scale testing (Phase 3)Looking for participantsNCT06607796
What this trial is testing

Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy

Who this might be right for
Lung Cancer
Zhou Chengzhi 180
Early research (Phase 1)UnknownNCT04612504
What this trial is testing

SynOV1.1 Intratumoral Injection Study

Who this might be right for
Hepatocellular Carcinoma
Beijing Syngentech Co., Ltd. 15
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Testing effectiveness (Phase 2)UnknownNCT05602792
What this trial is testing

T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorSarcomaHNSCC+4 more
ImmVira Pharma Co. Ltd 233
Testing effectiveness (Phase 2)Study completedNCT00038441
What this trial is testing

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Who this might be right for
GliomaBrain Neoplasms
M.D. Anderson Cancer Center 39
Testing effectiveness (Phase 2)Study completedNCT00554372
What this trial is testing

Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Jennerex Biotherapeutics 30
Very early researchActive Not RecruitingNCT04541108
What this trial is testing

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Who this might be right for
Solid Tumor
Presage Biosciences 15
Early research (Phase 1)Temporarily pausedNCT05938296
What this trial is testing

OHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection

Who this might be right for
Solid Tumor
Binhui Biopharmaceutical Co., Ltd. 29
Early research (Phase 1)Ended earlyNCT04502888
What this trial is testing

Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin

Who this might be right for
Cutaneous Squamous Cell CarcinomaSquamous Cell Carcinoma of Head and Neck
Shattuck Labs, Inc. 5
Early research (Phase 1)UnknownNCT05539157
What this trial is testing

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

Who this might be right for
Cutaneous TumorMalignant Solid Tumor
Immorna Biotherapeutics, Inc. 1
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Very early researchActive Not RecruitingNCT07144384
What this trial is testing

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Who this might be right for
Skin Basal Cell CarcinomaSkin Nodular Basal Cell CarcinomaSkin Squamous Cell Carcinoma
Ohio State University Comprehensive Cancer Center 4
Next Page